Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Brummer

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Brain : a Journal of Neurology|December 4, 2025
Beyond clinical labels: a molecular-structural framework for multiple sclerosis subtypingTobias Brummer, Vinzenz Fleischer
Current Opinion in Neurobiology|June 22, 2022
T cell-neuron interaction in inflammatory and progressive multiple sclerosis biologyTobias Brummer, Frauke Zipp, Stefan Bittner
Therapeutic Advances in Neurological Disorders|February 28, 2024
Anti-NMDA-receptor encephalitis and concurrent neuroborreliosis misdiagnosed for post-COVID-19-syndrome: a case reportTobias Brummer, Johannes Lotz, Christian Dresel, et al.
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Cellular and Molecular Life Sciences : CMLS|June 26, 2019
Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous systemHung-En Hsia, Johanna Tüshaus, Tobias Brummer, et al.
Journal of Neuroinflammation|November 14, 2023
Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammationTobias Brummer, Miriam Schillner, Falk Steffen, et al.
EMBO Molecular Medicine|March 6, 2019
NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's diseaseTobias Brummer, Stephan A Müller, Francisco Pan-Montojo, et al.
Therapeutic Advances in Neurological Disorders|November 24, 2025
Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesionsTobias Brummer, Gabriel Gonzalez-Escamilla, Falk Steffen, et al.
Brain Communications|July 11, 2022
Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkersTobias Brummer, Muthuraman Muthuraman, Falk Steffen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 13, 2018
The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradationTobias Brummer, Martina Pigoni, Armando Rossello, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Brain : a Journal of Neurology|December 4, 2025
Beyond clinical labels: a molecular-structural framework for multiple sclerosis subtypingTobias Brummer, Vinzenz Fleischer
Current Opinion in Neurobiology|June 22, 2022
T cell-neuron interaction in inflammatory and progressive multiple sclerosis biologyTobias Brummer, Frauke Zipp, Stefan Bittner
Therapeutic Advances in Neurological Disorders|February 28, 2024
Anti-NMDA-receptor encephalitis and concurrent neuroborreliosis misdiagnosed for post-COVID-19-syndrome: a case reportTobias Brummer, Johannes Lotz, Christian Dresel, et al.
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Cellular and Molecular Life Sciences : CMLS|June 26, 2019
Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous systemHung-En Hsia, Johanna Tüshaus, Tobias Brummer, et al.
Journal of Neuroinflammation|November 14, 2023
Spatial transcriptomics and neurofilament light chain reveal changes in lesion patterns in murine autoimmune neuroinflammationTobias Brummer, Miriam Schillner, Falk Steffen, et al.
EMBO Molecular Medicine|March 6, 2019
NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's diseaseTobias Brummer, Stephan A Müller, Francisco Pan-Montojo, et al.
Therapeutic Advances in Neurological Disorders|November 24, 2025
Prognostic value of blood-based biomarkers in multiple sclerosis patients in the absence of clinical relapses or new MRI lesionsTobias Brummer, Gabriel Gonzalez-Escamilla, Falk Steffen, et al.
Brain Communications|July 11, 2022
Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkersTobias Brummer, Muthuraman Muthuraman, Falk Steffen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 13, 2018
The metalloprotease ADAM10 (a disintegrin and metalloprotease 10) undergoes rapid, postlysis autocatalytic degradationTobias Brummer, Martina Pigoni, Armando Rossello, et al.
Pageof 2